BioMarin Pharmaceutical (BMRN) Stock Chart & Stock Price History $67.91 +0.01 (+0.01%) As of 09:39 AM Eastern Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends BioMarin Pharmaceutical Stock Price Performance 5 Day Performance+1.62%1 Month Performance+1.75%3 Month Performance-1.14%6 Month Performance-17.86%Year-To-Date Performance+3.32%1 Year Performance-31.40% Receive BMRN Stock News and Ratings via EmailSign-up to receive the latest news and ratings for BioMarin Pharmaceutical and its competitors with MarketBeat's FREE daily newsletter. Email Address Last time you’ll see this priced at $1.00 (Ad)When was the last time you bought something for a buck? I don’t even think you can buy anything at McDonalds for a dollar anymore!Click here to review Tim’s special offer before it’s too late. BMRN Stock Chart for Wednesday, January, 8, 2025 BMRN Chart by TradingView BioMarin Pharmaceutical Stock Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization01/07/2025$67.07$67.90+1.24%$68.85$66.911.35 million shs$12.94 billion01/06/2025$66.83$67.07+0.36%$67.75$66.701.03 million shs$12.78 billion01/03/2025$66.49$66.83+0.51%$67.50$66.44843,075 shs$12.74 billion01/02/2025$65.73$66.49+1.16%$66.74$65.86869,535 shs$12.67 billion01/01/2025$65.73$65.73$66.16$65.33790,724 shs$12.53 billion12/31/2024$65.45$65.73+0.43%$66.16$65.33790,724 shs$12.53 billion Get the Latest News and Ratings for BMRN and Related StocksEnter your email address below to receive the latest news and analysts' ratings for BioMarin Pharmaceutical and its competitors with MarketBeat's FREE daily newsletter. 12/30/2024$66.89$65.45-2.15%$66.46$65.241.21 million shs$12.47 billion12/27/2024$67.02$66.89-0.19%$67.47$66.38773,888 shs$12.75 billion12/26/2024$66.63$67.02+0.59%$67.10$66.21926,162 shs$12.77 billion12/25/2024$66.63$66.63$67.09$65.25439,028 shs$12.70 billion12/24/2024$66.27$66.63+0.54%$67.09$65.25439,028 shs$12.70 billion12/23/2024$65.66$66.27+0.93%$66.46$64.651.11 million shs$12.63 billion12/20/2024$65.00$65.66+1.02%$66.27$64.073.97 million shs$12.51 billion12/19/2024$64.69$65.00+0.48%$65.62$63.931.51 million shs$12.39 billion12/18/2024$67.19$64.69-3.72%$67.58$64.601.19 million shs$12.33 billion12/17/2024$65.54$67.19+2.52%$67.85$64.801.71 million shs$12.81 billion12/16/2024$66.01$65.54-0.71%$67.17$65.421.45 million shs$12.49 billion12/13/2024$66.26$66.01-0.38%$66.27$64.89763,074 shs$12.58 billion12/12/2024$65.97$66.26+0.44%$66.68$65.351.04 million shs$12.63 billion12/11/2024$66.43$65.97-0.69%$67.05$65.49802,558 shs$12.57 billion12/10/2024$66.81$66.43-0.57%$67.07$66.13824,891 shs$12.66 billion12/09/2024$66.74$66.81+0.10%$67.87$66.331.79 million shs$12.73 billion Related Companies ALNY Stock Chart BIIB Stock Chart UTHR Stock Chart INCY Stock Chart NBIX Stock Chart EXAS Stock Chart EXEL Stock Chart RGEN Stock Chart MDGL Stock Chart HALO Stock Chart Receive BMRN Stock News and Ratings via EmailSign-up to receive the latest news and ratings for BioMarin Pharmaceutical and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:BMRN) was last updated on 1/8/2025 by MarketBeat.com Staff From Our PartnersDeFi Coin on Verge of Breakout!The blueprint for millionaires is here. Don't let this be the missed opportunity you regret for years. Crypto 101 Media | SponsoredBuy this AI Stock Before Elon’s AnnouncementWith Trump back in office, xAI is primed to become the leader in generative AI, leaving competitors in the dus...InvestorPlace | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredNvidia’s Bold Move: Tackling Tech’s $1 Trillion CrisisTaiwan Semiconductor, a partner of Nvidia’s for more than two decades, has seen its shares explode as much as ...Weiss Ratings | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowCrypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happen...Crypto Swap Profits | Sponsoredliberals FOOLED by Elon’s shocking surpriseElon Musk and Donald Trump fooled everyone. They said it was to “save free speech”... Or “fix what the l...StocksToTrade | SponsoredHow this >10-cent coin is going to outperform Bitcoin Chris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | SponsoredStunning Trump Exec Order LeakedThis secret document contains stunning details about Donald Trump’s very first order of business… the minute h...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding BioMarin Pharmaceutical Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share BioMarin Pharmaceutical With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
